Navigation Links
PRA International Expands Presence in Asia:
Date:7/15/2009

RALEIGH, N.C., July 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of its office in South Korea, complementing the company's extensive network of Asian operations and partnerships. South Korea is widely regarded as the third most important pharmaceutical market in Asia and one of the most important Asian countries for clinical studies to support new drug registrations. China, Japan and South Korea have made a joint statement of cooperation on clinical research and Japan is now accepting South Korean clinical trial data for Japanese registration.

The government of South Korea has demonstrated its commitment to establishing the country as a key clinical research location in the Asian region through the formation of KoNECT, the South Korea National Enterprise for Clinical Trials. The increasing volume of multinational clinical research taking place across all trial phases is indicative of the organization's success. Pharmaceutical companies are attracted to the region by its many advantages, including:

  • Quality of clinical data
  • Progressive and efficient regulatory and ethical systems, exemplified by 30-day Approval Clock for INDs and adherence to ICH-GCP
  • Active engagement of world-class Investigators
  • Highly educated and committed clinical research professionals (CRAs, Study Nurses, and Study site personnel)
  • State-of-the-art trial facilities including 124 Korean FDA accredited sites and 12 regional clinical trial centers overseen by KoNECT
  • Proximity to vast patient populations

PRA has been providing clinical trial management services in South Korea since 2005, mainly through local partnerships. "Increasing customer expectations and project needs have prompted us to establish a legal entity and a local team of clinical professionals," noted Edward Ian, Sr. Director of Clinical Operations, PRA - Asia Pacific. "We anticipate significant growth of our operations in South Korea in the next few years to conduct clinical studies across a wide array of therapeutic indications, including oncology, neurology, respiratory disorders, infectious diseases and cardiovascular, endocrinology and metabolic disorders."

PRA's Executive VP of Product Registration for Europe, Africa and Asia-Pacific, Susan Stansfield, also commented: "The addition of the South Korean office to our existing Asian network, together with our continuing plans for expansion across the Asian region, further enhances PRA International's position as a CRO gateway to the world's most dynamic and rapidly expanding clinical research environment."

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.

Pharmaceutical Research Associates Korea Limited is located at:

    5th Floor, Pyeonghwan Building
    1579-6 Seocho-Dong, Seocho-Gu
    Seoul, South Korea 137-875
    T: +82-2-585-8155
    F: +82-2-585-3055


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship
2. American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens
3. Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance
4. Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards
5. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
6. Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress
7. Special Olympics Minnesota Athletes Take Part in Free Vision Screening at Lions Club International Annual Convention
8. Diageos DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts
9. International conference on reproductive science to be held in Pittsburgh July 18-22
10. CareFusion Corporation Launches International Jazz Festival Series
11. EnVivo to Share Results of its EVP-6124 Phase Ib/IIa Trial at The International Conference on Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: